The first bank of China fund to release its second Quarterly Report
As of 3 p.m. today, BOC fund disclosed the second quarterly report of nine products, including one flexible configuration product, two commodity based products and six debt based products. Among them, the net asset value of Bank of China Healthcare fund managed by Liu Xiao reached 1.264 billion yuan (A / C combined calculation) at the end of the second quarter, with a growth rate of 17.88% in the quarter. Compared with the previous quarter, Beida pharmaceutical, Aier ophthalmology and Lizhu group were newly added to the top ten heavy position stocks of the fund; And Yunnan Baiyao increased its position by 208500 shares, which is the largest position of the fund; Changchun hi tech, Zhifei biology, humanwell medicine, etc. withdrew from the top ten heavy position stocks. Fund managers said that their positions focused on innovative drugs, cro / cdmo and other industry leaders, and focused on the rise of domestic life technology industry supply chain.
This text is a result of machine translation.
Related companies：
In depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Nov 29, 2021 07:59 PM
· Healthcare
Boten Co., Ltd.: direnavir API has passed who PQ certification
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
Briefing Oct 30, 2021 07:57 AM
· Healthcare
Economic Daily: enterprise investment should not abandon the main business
In depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Briefing Oct 29, 2021 11:38 AM
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Briefing Oct 28, 2021 03:23 PM
· Healthcare
Yunnan Baiyao responded that it lost 1.5 billion in stock speculation: it will gradually optimize the structure and gradually withdraw from securities investment
Briefing Oct 27, 2021 04:38 PM
· Healthcare
Wanyi Technology: the net profit in the first three quarters increased by 286.04% to 5.2454 million yuan
Briefing Oct 19, 2021 06:23 PM
Aier ophthalmology: acquisition of partial equity of Anshan Aier, Cangzhou Aier, Fuyang Aier, Langfang Aier and Qinhuangdao Aier
See more
Read next
In depth
Financials, Technology · Analysis
WIM2021 New York: Speakers to Inspire the Most Innovative Minds
Dec 06, 2021 04:31 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.